Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Attention Bias Modification Treatment (ABMT) for Patients With Post Traumatic Stress Disorder (PTSD)

NCT01368302 is registered in ClinicalTrials.gov with Tel Aviv University as lead sponsor.

NCT NCT01368302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01368302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Attention Bias Modification Treatment (ABMT) for Patients With Post Traumatic Stress Disorder (PTSD)
Lead sponsor
Tel Aviv University
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2011
Completion date
March 31, 2013
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention bias modification treatment (abmt)